• Cognitive Support
• Neurological Health
• Chronic Fatigue
Serving Size: 1 Capsule
N-Acetyl-L-Carnitine (HCl) … 500 mg
Non-medicinal ingredients: ascorbic acid. Capsule : hypromellose, water.
AOR Guarantees: that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, corn, nuts, dairy, soy, eggs, fish, shellfish, or any animal byproduct.
Source: Pharmaceutical synthesis
What Is It?
ALCAR is N-acetyl-L-carnitine, a short-chain acetylated ester of L-carnitine, a compound found ubiquitously in mammalian tissues. ALCAR is thought to be able to cross the blood-brain barrier more easily than L-carnitine, making ALCAR usage more targeted toward cognitive function.
What Does It Do?Primary Uses: Extensive research has documented ALCAR's ability to rejuvenate mitochondrial bioenergetics, and ALCAR has been found to support cognitive function and reduce the symptoms of mild cognitive impairment.Secondary Uses: L-carnitine supplements can also increase L-carnitine levels in those who are deficient due to the use of medications, disease, in strict vegetarians, dieters, and those with heart or circulatory conditions. Some people use L-carnitine for athletic performance and endurance, muscle disorders, male infertility, Rett syndrome, chronic fatigue syndrome, anorexia, attention deficit-hyperactivity disorder (ADHD), thyroid imbalances, leg ulcers, high cholesterol and lyme disease.
Who Should Take It?
ALCAR is beneficial for people of all walks of life including the young, middle-aged and elderly, vegetarians, brain rehab patients, those experiencing chronic fatigue or who have metabolic problems. Better yet, the positive cognitive effects seem to persist after ceasing short-term supplementation! This makes it a worthwhile investment with good returns for anyone looking for additional cognitive, metabolic and general health support.
Take 1 capsule one to four times daily without food, or as directed by a qualified health care practitioner.
Furlong JH. Acetyl-L-Carnitine: Metabolism and applications in clinical practice. Altern Med Rev 1996;1:85-93.
Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman CW, Ames BN. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci U S A 2002 Feb 19; 99(4): 2356-61.
Montgomery SA, Thal LJ, Amrein R.Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.Int Clin Psychopharmacol 2003 Mar; 18(2): 61-71.
Rai G, Wright G, Scott L, et al. Double-blind, placebo controlled study of acetyl-l-carnitine in patients withAlzheimer's dementia. Curr Med Res Opin 1990;11:638-647.Shigenaga MK, Hagen TM and Ames BN. Oxidative damage and mitochondrial decay in aging. 1994. PNAS; 91(23): 10771-10778.
Spagnoli A, Lucca U, Menasce G, et al.Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology.1991;41:1726-1732.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.